Lantheus Holdings (LNTH) Intangibles (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly Intangibles came in at $936.5 million in Q1 2026, up 509.1% year-on-year from $153.7 million in Q1 2025, and up 29.56% on a QoQ basis from $722.8 million in Q4 2025.
Lantheus Holdings (LNTH) Intangibles (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Intangibles data on file, last reported at $936.5 million in Q1 2026.
- On a quarterly basis, Intangibles rose 509.1% year-over-year to $936.5 million in Q1 2026; TTM through Mar 2026 was $936.5 million, a 509.1% increase from a year earlier, with the FY2025 full-year figure at $722.8 million, up 346.82% from the prior year.
- Intangibles for Q1 2026 stood at $936.5 million, up from $722.8 million in the prior quarter.
- Over the last five years, Intangibles for LNTH reached as high as $936.5 million in Q3 2025 and fell as low as $40.3 million in Q2 2024.
- Historically, Intangibles has averaged $335.0 million across 5 years, with a median of $221.0 million in 2023.
- Across the five-year window, Intangibles slumped 81.77% in 2024 and surged 793.17% in 2025, its largest moves.
- Year by year, Intangibles stood at $315.3 million in 2022, then slumped by 51.79% to $152.0 million in 2023, then increased by 6.43% to $161.8 million in 2024, then surged by 346.82% to $722.8 million in 2025, then climbed by 29.56% to $936.5 million in 2026.
- Per Business Quant data, the three most recent Intangibles figures were $936.5 million in Q1 2026, $722.8 million in Q4 2025, and $936.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 34.07 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 959.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 21.80 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 473.93 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.48 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.23 Bn |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn | 936.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 936.46 Mn |
| Dec 31, 2025 | 722.78 Mn |
| Sep 30, 2025 | 936.46 Mn |
| Jun 30, 2025 | 359.95 Mn |
| Mar 31, 2025 | 153.75 Mn |
| Dec 31, 2024 | 161.76 Mn |
| Sep 30, 2024 | 173.61 Mn |
| Jun 30, 2024 | 40.30 Mn |
| Mar 31, 2024 | 142.05 Mn |
| Dec 31, 2023 | 151.99 Mn |
| Sep 30, 2023 | 163.29 Mn |
| Jun 30, 2023 | 221.00 Mn |
| Mar 31, 2023 | 219.86 Mn |
| Dec 31, 2022 | 315.29 Mn |
| Sep 30, 2022 | 323.59 Mn |
| Jun 30, 2022 | 331.90 Mn |
| Mar 31, 2022 | 340.20 Mn |
| Dec 31, 2021 | 348.51 Mn |
| Sep 30, 2021 | 356.88 Mn |
| Jun 30, 2021 | 365.26 Mn |